Jenny is currently serving as the Chief Operating Officer and Chief Investment Officer of
a soon-to-launch healthcare startup with the vision to merge the for-profit and non-profit
worlds in funding science for all. Previously, she was a Managing Partner at Adjuvant
Capital, a life sciences investment fund dedicated to mid- to late-stage research and
development of products addressing significant global health challenges affecting lower-
and middle-income countries. In that role, Jenny served on numerous boards including
Antiva Biosciences (US), 54gene (Nigeria), ChromaCode (US), Evofem Biosciences
(US), and as a board observer on Excision Biotherapeutics (US).
Prior to Adjuvant, Jenny was a Partner at the Bill & Melinda Gates Foundation Strategic
Investment Fund where she led transactions across the foundation’s focus areas in
global health, agriculture, nutrition, and education. She has always been passionate
about improving the health and lives of those living in low-resourced settings and spent
time working in Kenya and China. In Kenya, Jenny was a volunteer consultant for
Technoserve, a non-profit business consultancy for small-holder farmers and small to
medium businesses.
Jenny has worked in finance for over 20 years, beginning as an investment banker
advising corporate clients in mergers and acquisitions and debt and equity financings at
Goldman Sachs’ Hong Kong, New York, and San Francisco offices. In her non-profit
work, she serves on the boards of ReSurge International, the Global Fund for Women,
the Hamlin School and on the Advisory Board of the Harvard Public Health Magazine.